## DD: DuPont de Nemours, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -1.0% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: declining volume (51% of avg), momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.36)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. DuPont (DD) CEO exercises 9,011 options and sells 9,011 shares in Nov 2025**
- Source: Stock Titan | 20251201T165700 | Neutral | Relevance: 99%
- DuPont's CEO and director, Lori Koch, exercised 9,011 stock options at $28 per share and subsequently sold 9,011 shares of common stock at a weighted average price of $39.4619 on November 28, 2025. Following these transactions, the CEO directly owns 288,325.6878 shares of DuPont common stock. The exercised options were non-qualified, granted in 2019, and set to expire in 2026.

**2. DuPont de Nemours, Inc. $DD Shares Bought by Edgestream Partners L.P.**
- Source: MarketBeat | 20251202T094642 | Neutral | Relevance: 99%
- Edgestream Partners L.P. significantly increased its stake in DuPont de Nemours ($DD) by 323.5% in Q2 2025, now holding 102,151 shares valued at $7.01 million. This increase in institutional ownership comes as DuPont's board authorized a $2.00 billion stock buyback, suggesting management believes the stock is undervalued, despite recent insider selling by top executives. The article also provides details on other institutional ownership changes, stock performance, earnings data, dividend information, and recent analyst ratings for DuPont.

**3. DuPont (DD) director adds 1,267 shares through dividend reinvestment in Form 4**
- Source: Stock Titan | 20251202T163300 | Neutral | Relevance: 99%
- A DuPont de Nemours, Inc. director, Alexander M. Cutler, acquired 1,267.7484 shares of DuPont common stock on November 26, 2025, at a price of $39.44 per share through dividend reinvestment. This transaction increased the director's directly held stake to 75,473.223 shares. The Form 4 filing indicates that cash dividends were automatically used to purchase the additional shares.

**4. Dupont De Nemours Insider Sold Shares Worth $355,574, According to a Recent SEC Filing**
- Source: MarketScreener | 20251201T221100 | Neutral | Relevance: 99%
- An insider at Dupont De Nemours sold shares valued at $355,574, as reported in a recent SEC filing. This transaction was published on December 1, 2025, at 5:11 pm EST by MT Newswires. The article also provides recent analyst rating adjustments and company news related to DuPont de Nemours, Inc.

**5. Hsbc Holdings PLC Sells 9,861 Shares of DuPont de Nemours, Inc. $DD**
- Source: MarketBeat | 20251201T095426 | Neutral | Relevance: 98%
- Hsbc Holdings PLC reduced its stake in DuPont de Nemours, Inc. by 1.1% in the second quarter, selling 9,861 shares and owning 862,292 shares worth $59.12 million. Other institutional investors also adjusted their holdings, while analysts provided updated ratings and price targets for DuPont de Nemours. The company also announced a quarterly dividend and a stock buyback authorization.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | RBC Capital | $48 | $100 | -52% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | RBC Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 11 ($0.27M) |
| Sells | 3 ($0.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+6.7%)
- Blackrock Inc.: 7.6% (-5.1%)
- State Street Corpora: 4.3% (-0.9%)
- Geode Capital Manage: 2.6% (+1.5%)
- Nuveen, LLC: 2.1% (+7.4%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.78 indicates undervaluation relative to growth. Forward P/E 18.3x attractive for 25% earnings growth. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.2B |
| Beta | 1.14 |
| 52W Range | $22.50 - $41.27 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.78 |
| Forward P/E | 18.3 |
| Current P/E | 22.9 |
| YoY Growth | 24.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 1.4% to -1.0% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.0pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 51% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.96% (CS: 48) | Neutral |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 1.112x | Above |
| vs SMA200 | 1.255x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.52
- **Stop Loss:** $37.36 (5.5% risk)
- **Target:** $41.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 462
- **Position Value:** $18,258.24
- **Portfolio %:** 18.26%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-10 (Est: $0.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.98 | $1.09 | +11.2% |
| 2025Q2 | $1.06 | $1.12 | +5.5% |
| 2025Q1 | $0.95 | $1.03 | +8.1% |
| 2024Q4 | $0.98 | $1.13 | +15.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*